COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT
CollPlant Biotechnologies Announces Private Placement Of 989,301 Shares And Warrants To Purchase Up To 1,483,952 Shares At $3.74/Unit
LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations
CollPlant Biotechnologies Unit LightSolver Files U.S. Provisional Patent Application For Expansion Of Its All-Optical, Laser-Based Computing Platform
COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
CollPlant Biotechnologies Q2 Adj. EPS $(1.69) Misses $(0.24) Estimate, Sales $108.000K Miss $1.466M Estimate
LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads
CollPlant Announces Publication Of Joint Research Conducted By Its Subsidiary LightSolver Showing Photonic Computing Advantage Over GPUs
CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement
CollPlant Biotechnologies Regains Nasdaq Compliance
CollPlant Biotechnologies Ltd. (CLGN) Discusses Acquisition of Lightsolver and Strategic Entry Into High-Performance Photonic Computing - Slideshow
CollPlant Biotechnologies Ltd. (CLGN) Discusses Acquisition of Lightsolver and Strategic Entry Into High-Performance Photonic Computing Transcript
CollPlant to Host LightSolver Investor Webinar on September 17, 2026
COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION
COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR
COLLPLANT ANNOUNCES REVERSE SHARE SPLIT
CollPlant Biotechnologies Board Approves 1-For-10 Reverse Share Split, Effective September 4
COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS
CollPlant Biotechnologies Files Prospectus For Offering 31.047M Shares On Behalf Of Selling Shareholders
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.